November 12, 2012 15:08
FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)
MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.
The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.
The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.
Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.
The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.
AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.
The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.
According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.
Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.
(Our editorial staff can be reached at email@example.com)
April 27, 2015
Putin hopeful rapprochement with Kazakhstan continues after Nazarbayev's re-election
PUTIN CONGRATULATES NURSULTAN NAZARBAYEV ON WINNING KAZAKHSTAN PRESIDENTIAL ELECTIONS - KREMLIN PRESS SERVICE
Ninety-one Ukrainians inaccessible in Nepal - Perebiynis
Russian-Chinese consortium only bidder for design of Moscow-Kazan HSR line
CIS observers say Kazakh presidential elections have alternative, leader enjoys indisputable authority
CIS monitors do not observe serious violations in Kazakh presidential elections
Moscow press review for April 27, 2015
Kazakh presidential elections held in strict compliance with law - CIS mission chief
Final results of Kazakh presidential elections to be posted no later than on May 3
Nazarbayev wins 97.7% of vote in Kazakhstan presidential elections - tentative report
THERE WAS ALTERNATIVE IN KAZAKHSTAN PRESIDENTIAL ELECTION BUT INCUMBENT LEADER OF THE COUNTRY ENJOYS INDISPUTABLE AUTHORITY - CIS ELECTION OBSERVATION MISSION
KAZAKHSTAN PRESIDENTIAL ELECTIONS HELD IN STRICT COMPLIANCE WITH THE LAW - CIS ELECTION OBSERVATION MISSION CHIEF
CIS ELECTION MONITORS DID NOT OBSERVE SERIOUS VIOLATIONS IN KAZAKHSTAN PRESIDENTIAL ELECTIONS - MISSION CHIEF LEBEDEV